凯莱英 港股通 空最新增减持 (2026-02-10) 官网 ( 06821.hk) | 27.35 | 1.58 | 1.41% | 上市时间2021-12-10股价83.15港币涨跌幅2.21%成交金额2,489.99万港币换手率0.08%市值300.07亿港币H股市值23.14亿港币总股本3.61亿H股本2,783.45万每手股数100上市至今年化投资收益率-22.64%港股通持仓占H股比例42.92% (8.82亿港币2026-03-03) 累计做空占H股比例4.09% (8,932.99万港币2026-02-27) | |||
| 所属三级行业药品 (恒生) | 市盈率 | 30.34 | 市净率 | 2.93 | 股息率 | 1.11% | 恒生:医疗保健业药品及生物科技药品 |
| 所属指数指数纳入纳出 | |||||||
| 同股同权 | 查看历史折扣 | ||||||
| 备注 (4): | 双击编辑备注 |
凯莱英(06821) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 孫雪嬌 | Independent Non Executive Director - A/F | 2023-10-18 | -- | |
| 2 | 李家聰 | Independent Non Executive Director | 2021-06-16 | -- | |
| 3 | 張婷 | Non Executive Director | 2021-02-09 | -- | |
| 4 | 王青松 | Independent Non Executive Director | 2019-04-18 | -- | |
| 5 | 張達 | Executive Director | 2018-08-07 | -- | |
| 6 | 張昆 | Independent Non Executive Director - A/F | 2017-01-16 | 2023-10-18 | |
| 7 | HONG Hao | Executive Director | Chairman, CEO | 2011-07-18 | -- |
| 8 | 洪亮 | Executive Director | 2011-07-18 | -- | |
| 9 | SONG Ye | Non Executive Director | 2011-07-18 | -- | |
| 10 | 楊蕊 | Executive Director | 2011-07-18 | -- |